Ambu stock gains 6.30 percent as Q3 margin guidance holds

Published on 10/06/2026 at 14:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu stock was trading at DKK 72.50 on October 6, 2026, after Q3 organic growth reached 10.3 percent. Reported EBIT margin rose to 13.5 percent.

Schwarzweiß-Reportage aus dem Operationssaal mit Endoskopie-Technik — Ambu A/S (DK0060946788) dokumentiert schwarzweiß eine dramatische Operationssaal-Szene mit Endoskopie-Ausrüstung im Krankenhaus, Illustration mit AI erstellt.

Ambu A/S (ISIN DK0060946788) was trading at DKK 72.50 on Nasdaq Copenhagen on October 6, 2026, up 6.30 percent, as the company carried its Q3 2025/26 growth message into the new quarter. The earnings update reported 10.3 percent organic growth and a 13.5 percent reported EBIT margin, according to Yahoo Finance on August 26, 2026.

Q3 margin improves by 2.2 points

Ambu's Q3 revenue reached DKK 1.64 billion, while net income came to DKK 156.0 million. Earnings per share increased to DKK 0.59 from DKK 0.46 in Q3 2024/25, a quantified improvement that gives the market more than a topline growth story.

The reported EBIT margin rose 2.2 percentage points from the same quarter a year earlier, while adjusted EBIT margin was 12.5 percent. Yahoo Finance also reported that management maintained 12%-14% full-year EBIT margin guidance.

Endoscopy growth reaches 16 percent

Endoscopy Solutions grew 16 percent in Q3 and accounted for 64 percent of Ambu's revenue. Respiratory was the strongest named contributor at 17.1 percent organic growth, while Anesthesia and Patient Monitoring returned to positive growth at 1.6 percent.

The mix matters because Ambu's endoscopy business is expanding faster than the rest of the portfolio. Management also described competition in ureteroscopy and customer volume pressure in selected US anesthesia accounts, making execution and margin conversion important for the next report.

Analysts see DKK 81.77 target

MarketScreener lists a Hold consensus from 8 analysts and an average price target of DKK 81.77. Against the DKK 72.50 intraday price, the average target lies 12.8 percent above the price.

That valuation gap contrasts with the stock's current range. Ambu's DKK 72.50 quote stood above the DKK 56.25 52-week low and below the DKK 111.80 high, while market capitalization was DKK 19.3 billion.

Ambu stock trades above DKK 72

Ambu stock was last at DKK 72.50 on Nasdaq Copenhagen on October 6, 2026, at 2:01 p.m. CEST, with a daily high of DKK 72.65 and a daily low of DKK 68.80. The session volume was 514,706 shares.